|
| |
| | | 66138 | | 31.01.2017 | | Pfizer AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ibrance 75 mg | Hartkapseln | Capsules (Palbociclibum 75 mg) | L01EF01 | CI | | 02 | Ibrance 100 mg | Hartkapseln | Capsules (Palbociclibum 100 mg) | L01EF01 | CI | | 03 | Ibrance 125 mg | Hartkapseln | Capsules (Palbociclibum 125 mg) | L01EF01 | CI |
|
|
|
